Metraipolis › archive › dc_da646ccfae61

METTL3 Increases Temozolomide Resistance in MGMT-Negative Glioblastoma by Enhancing CBX5 mRNA Stability in an m6A-IGF2BP2-Dependent Manner — Europe PMC PMID:42817804

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42817804
DOI
10.1002/cns.71164
License (as archived)
solo-consultazione
Archived
2026-10-07T15:00:14.982Z
SHA-256 of the archived text
8b7e8eed93241d2bb0aef582316085adf96a22828c2344108e4ea689d132485b
Stable URL of this page
https://metraipolis.com/documento/dc_da646ccfae61

How to cite

METTL3 Increases Temozolomide Resistance in MGMT-Negative Glioblastoma by Enhancing CBX5 mRNA Stability in an m6A-IGF2BP2-Dependent Manner — Europe PMC PMID:42817804 — Europe PMC (en), https://europepmc.org/article/MED/42817804 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_da646ccfae61 (Metraipolis archive dc_da646ccfae61, sha256 8b7e8eed93241d2bb0aef582316085adf96a22828c2344108e4ea689d132485b)
BibTeX
@misc{dcda646ccfae61,
  title = {METTL3 Increases Temozolomide Resistance in MGMT-Negative Glioblastoma by Enhancing CBX5 mRNA Stability in an m6A-IGF2BP2-Dependent Manner — Europe PMC PMID:42817804},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42817804},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_da646ccfae61; sha256 8b7e8eed93241d2bb0aef582316085adf96a22828c2344108e4ea689d132485b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42817804. Agents can read the archived copy with the MCP tool read_document.